Company Data
Travere Therapeutics Inc.
Ticker
TVTX
Current Price
$27.87 -1.87%
Market Cap
$2.5B
Price Target
Refer to Report
Volume
2.1M
52wk Range
$12.91 - $42.13
Overview
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on the development and commercialization of therapies for people living with rare diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN) – rare kidney disorders that often lead to end-stage kidney disease.